• Induction chemotherapy before surgical resection increases survival compared with surgical resection alone in patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC). (nih.gov)
  • We hypothesized that, following a response to induction chemotherapy, surgical resection would be superior to thoracic radiotherapy as locoregional therapy. (nih.gov)
  • Responding patients were subsequently randomly assigned to surgical resection or radiotherapy. (nih.gov)
  • A total of 167 patients were allocated to resection and 165 to radiotherapy. (nih.gov)
  • Median and 5-year overall survival for patients randomly assigned to resection versus radiotherapy were 16.4 versus 17.5 months and 15.7% versus 14%, respectively (hazard ratio = 1.06, 95% CI = 0.84 to 1.35). (nih.gov)
  • In selected patients with pathologically proven stage IIIA-N2 NSCLC and a response to induction chemotherapy, surgical resection did not improve overall or progression-free survival compared with radiotherapy. (nih.gov)
  • The US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) in the adjuvant setting for patients with stage IB-IIIA non-small cell lung cancer (NSCLC) following resection and platinum-based chemotherapy. (medscape.com)
  • The standard GBM treatment includes surgical resection with adjuvant radiotherapy and chemotherapy 2 . (nature.com)
  • A multimodal radiotherapy-containing approach is a well-tolerated component of treatment for patients with osteosarcomas undergoing programed resection, allowing low toxicity rates while maintaining high local control rates. (cun.es)
  • Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual-center retrospective study. (dana-farber.org)
  • With regards to treatment, the role of surgical resection, radiotherapy, chemotherapy, and tumor-treating fields will be presented. (cancernetwork.com)
  • Adjuvant radiotherapy has been to improve local control, with variable effect on overall survival after complete resection. (medscape.com)
  • 3 The current standard of treatment involves maximal surgical resection followed by concurrent radiation therapy and chemotherapy with the DNA alkylating agent temozolomide (TMZ). (bmj.com)
  • Radiotherapy is the standard of care for SPB, even in patients who have undergone complete tumor resection. (hindawi.com)
  • Treatment is surgical resection and chemotherapy for nodal involvement. (msdmanuals.com)
  • Treatment is surgical resection and chemotherapy for nodal. (msdmanuals.com)
  • Adult patients with newly diagnosed glioblastoma were randomly assigned to receive either standard radiotherapy or identical radiotherapy with concomitant temozolomide followed by up to six cycles of adjuvant temozolomide. (nih.gov)
  • Methylation of the MGMT promoter was the strongest predictor for outcome and benefit from temozolomide chemotherapy. (nih.gov)
  • Benefits of adjuvant temozolomide with radiotherapy lasted throughout 5 years of follow-up. (nih.gov)
  • and temozolomide chemotherapy alone. (cochrane.org)
  • From the abstract: 'Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients with resectable non-small-cell lung cancer (NSCLC). (cdc.gov)
  • The immunotherapy has already been approved for several other NSCLC indications , including as first-line treatment along with pemetrexed and platinum chemotherapy for patients with metastatic nonsquamous NSCLC without EGFR or ALK genomic tumor aberrations. (medscape.com)
  • Radiotherapy Dose in Patients Receiving Immunotherapy. (dana-farber.org)
  • The treatment of BC is very complex, and include the combination of surgery, chemotherapy, radiotherapy, hormonetherapy and immunotherapy. (isciii.es)
  • Clinical use of a combination of radiotherapy and chemotherapy continues to increase, while the development of immunotherapy, such as checkpoint inhibitors, offers hope in improving treatment outcome. (hkmj.org)
  • There were no significant differences between the various methods of sequencing adjuvant therapy for local recurrence-free survival, overall survival, relapse-free survival and metastasis-free survival based on 1166 randomised women in three trials. (cochrane.org)
  • Within the MET141 low-risk subgroup (lowest 25th percentile of scores), 95% of patients were free of metastasis at 15 years, even in the absence of adjuvant endocrine therapy. (lu.se)
  • Treatment is primarily surgical, but in patients with lymph node metastasis, postoperative radiotherapy is recommended as well. (medscape.com)
  • Postoperative radiotherapy was administered to 62 (40%) of patients in the surgery arm. (nih.gov)
  • In its early stages, the cancer is typically treated through surgery, radiation and chemotherapy. (wikipedia.org)
  • In later stages where surgery is not possible or the cancer has spread from the initial localised area, treatment is limited to chemotherapy and in some cases further targeted therapy. (wikipedia.org)
  • Neoadjuvant chemotherapy is the type used before surgery. (healthline.com)
  • The term neoadjuvant chemotherapy should be used to refer to chemotherapy before surgery. (healthline.com)
  • Neoadjuvant chemotherapy , which is chemotherapy before surgery, is being used increasingly more often to treat breast cancer that has spread locally. (healthline.com)
  • Traditionally, the standard of care for people with rare anaplastic oligodendrogliomas and anaplastic oligoastrocytomas (brain tumours) has been surgery followed by radiotherapy. (cochrane.org)
  • However, the benefit of adjuvant (post-surgery) chemotherapy and radiotherapy is still unclear. (cochrane.org)
  • After surgery, the participants had to have received radiotherapy alone, chemotherapy alone or radiotherapy plus chemotherapy. (cochrane.org)
  • One study was able to demonstrate a significant survival benefit for the addition of chemotherapy to radiotherapy after surgery, compared with radiotherapy alone. (cochrane.org)
  • Furthermore, in one study, these specific chromosome deletions and mutations predicted which group of participants derived benefit from the addition of chemotherapy to radiotherapy after surgery. (cochrane.org)
  • 2 cm in diameter, as adjuvant therapy following neoadjuvant chemotherapy and surgery (see sections 4.4 and 5.1). (who.int)
  • This review examined the current evidence on the best way to administer chemotherapy and radiotherapy following breast-conserving surgery. (cochrane.org)
  • The evidence produced by these three well-conducted trials suggests that recurrence of a woman's cancer and her chances of dying from breast cancer are similar regardless of the order of the treatments, provided that both radiotherapy and chemotherapy are commenced within seven months of the surgery. (cochrane.org)
  • After surgery for localised breast cancer, radiotherapy (RT) improves both local control and breast cancer-specific survival. (cochrane.org)
  • After surgery, patients may undergo adjuvant chemotherapy and/or radiotherapy to reduce the risk of recurrence. (sgh.com.sg)
  • Patients with advanced oesophageal cancer or those with poor general health may still be candidates for curative surgery after a period of tube feeding or intravenous feeding combined with neo-adjuvant chemotherapy and/or radiotherapy. (sgh.com.sg)
  • In patients with medially inoperable or unresectable tumors, primary radiotherapy, with or without chemotherapy, has provided a survival advantage and significant palliation over stent placement or bypass surgery alone. (medscape.com)
  • Additional treatment in the form of chemotherapy or radiotherapy given after surgery to reduce the risk of the tumour coming back. (christie.nhs.uk)
  • In the open-label international trial, 358 patients with stage IB to IIIA resectable disease were randomly assigned between March 2017 and November 2019 to receive neoadjuvant treatment with nivolumab at 360 mg plus platinum-doublet chemotherapy (n = 179) or platinum-doublet chemotherapy alone (n = 179) every 3 weeks for three cycles before definitive surgery. (ascopost.com)
  • The addition of nivolumab to neoadjuvant chemotherapy did not increase the incidence of adverse events or impede the feasibility of surgery. (ascopost.com)
  • Surgery and locoregional radiotherapy may offer optimal clinical and radiological outcomes but have a limited role in improving local tumor control and overall survival. (iiarjournals.org)
  • Radiotherapy was delivered to ipsilateral axil- cancer patients in the future, it is essential to increase our lary and supraclavicular lymph nodes and the remaining knowledge in mechanisms responsible for drug resistance, breast parenchyma after breast conservation surgery or tho- and to define reliable indicators for response to therapy. (lu.se)
  • Clinical studies reporting at least one outcome following curative surgery and adjuvant therapy for comparison of patients with either infranotch T4b (IN-T4b) or T4a tumour. (bvsalud.org)
  • Experimental Design: We performed a whole-transcriptome analysis of SweBCG91-RT, a randomized phase III trial of ± radiotherapy after breast-conserving surgery for node-negative stage I-IIA breast cancer. (lu.se)
  • The study was carried out to exhaust the scientific literature regarding surgery associated with radiotherapy in patients suffering from metastatic spinal cord compression and to assist in the decision of oncology physicians and professionals in choosing the best treatment for the patient. (bvsalud.org)
  • The researchers carried out a descriptive study using bibliometric and scientometric methods and found that the combination of surgery with postoperative radiotherapy is effective and more efficient than these alone for the treatment of patients affected by metastatic neurological compression. (bvsalud.org)
  • Decompression surgery and postoperative radiotherapy was mostly palliative. (bvsalud.org)
  • Radiotherapy can be considered in cases of local disease that is poorly differentiated or for those who are poor candidates for surgery. (medscape.com)
  • this is known as adjuvant therapy. (melbendo.com.au)
  • Chemotherapy is a drug therapy that's used to treat many different types of cancer. (healthline.com)
  • When chemotherapy is used at the beginning of your cancer treatment and before starting radiation therapy , it's referred to as induction chemotherapy. (healthline.com)
  • The goal of induction chemotherapy is to shrink tumors before beginning radiation therapy. (healthline.com)
  • Keep reading as we take a look at when induction chemotherapy may be used and how it compares to consolidation therapy and other types of chemotherapy. (healthline.com)
  • Concurrent chemotherapy radiation therapy is when chemotherapy and radiation therapy are performed together. (healthline.com)
  • Induction chemotherapy is the type used before radiation therapy. (healthline.com)
  • However, induction chemotherapy should be used when chemotherapy occurs before radiation therapy. (healthline.com)
  • The goal of induction chemotherapy is to reduce tumor size to make it easier for radiation therapy to get rid of cancer cells and to reduce the chances of cancer spreading to distant parts of your body. (healthline.com)
  • Induction chemotherapy is used as a first-line treatment for cancer to prepare you for radiation therapy. (healthline.com)
  • During consolidation therapy, chemotherapy drugs are administered in higher doses . (healthline.com)
  • The combination of chemotherapy drugs administered is often similar as during induction therapy. (healthline.com)
  • Clinical trials have found that induction chemotherapy seems to be at least equally as effective as chemotherapy and radiation therapy together for treating head and neck cancers. (healthline.com)
  • A 2016 study found evidence that patients with stage 2 or stage 3 non-small cell lung cancer may benefit from induction chemotherapy before concurrent chemotherapy and radiation therapy. (healthline.com)
  • Acute leukemias are often treated with induction therapy and consolidation chemotherapy once the cancer is in remission. (healthline.com)
  • The role of adjuvant radiotherapy and chemotherapy remains uncertain and use of hormonal therapy has not been fully investigated. (hindawi.com)
  • If they are used sequentially, the radiotherapy or the chemotherapy could be used first and concerns have been expressed that the effectiveness of the therapy that is delayed might be reduced. (cochrane.org)
  • However, the best sequence of administering these two types of adjuvant therapy for early-stage breast cancer is unclear. (cochrane.org)
  • To the best of our knowledge, our case is the sixth case that primary adenosarcomas arising in vaginal endometriosis and it is the first case living without chemo-therapy or radiotherapy. (scirp.org)
  • Tamoxifen has been the gold standard adjuvant hormonetherapy for the treatment of postmenopausal women with hormone-receptor-positive early BC for many years, but the third-generation aromatase inhibitors (letrozole, anastrozole, and exemestane) are now recommended as the preferred therapy. (isciii.es)
  • Adjuvant and preoperative radiation therapy has been used to reduce tumors in an effort to make them resectable. (medscape.com)
  • This therapy has been performed with and without concurrent chemotherapy as a radiation sensitizer. (medscape.com)
  • The benefit of nivolumab was maintained in analysis adjusted for optional receipt of adjuvant therapy (HR = 0.65, 95% CI = 0.47-0.90). (ascopost.com)
  • Considerable inter-hospital variations were observed in preoperative work-up, tumor diagnostics, surgical strategies, techniques for intraoperative guidance, as well as choice and timing of adjuvant therapy. (lu.se)
  • Purpose: There is currently no molecular signature in clinical use for adjuvant endocrine therapy omission in breast cancer. (lu.se)
  • Given the unique trial design of SweBCG91-RT, where adjuvant endocrine and chemotherapy were largely unadministered, we sought to evaluate the potential of transcriptomic profiling for identifying patients who may be spared adjuvant endocrine therapy. (lu.se)
  • Ninety-two percent of patients were untreated by both adjuvant endocrine therapy and chemotherapy. (lu.se)
  • Conclusions: Transcriptomic profiling identifies patients with an excellent outcome without any systemic adjuvant therapy in clinically low-risk patients of the SweBCG91-RT and METABRIC cohorts. (lu.se)
  • those with more advanced stage are candidates for chemotherapy or radiation therapy. (medscape.com)
  • In 2004, a randomised phase III trial by the European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clinical Trials Group (NCIC) reported improved median and 2-year survival for patients with glioblastoma treated with concomitant and adjuvant temozolomide and radiotherapy. (nih.gov)
  • Does giving chemotherapy, radiotherapy or both improve survival in people with rare (anaplastic oligodendrogliomas and oligoastrocytomas) brain tumours? (cochrane.org)
  • In patients at risk of harbouring micro-metastatic disease, adjuvant chemotherapy (CT) improves 15-year survival. (cochrane.org)
  • In a study of 1636 patients with unresectable localized intrahepatic cholangiocarcinoma, the addition of radiation to chemotherapy was associated with an improvement in overall survival. (medscape.com)
  • As reported in The New England Journal of Medicine by Forde et al, the phase III CheckMate 816 trial has shown improved pathologic complete response rate and event-free survival with the addition of nivolumab to platinum-based chemotherapy in the neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC). (ascopost.com)
  • The addition of nivolumab to chemotherapy significantly improved event-free survival. (ascopost.com)
  • The investigators concluded: "In patients with resectable NSCLC, neoadjuvant nivolumab plus chemotherapy resulted in significantly longer event-free survival and a higher percentage of patients with a pathological complete response than chemotherapy alone. (ascopost.com)
  • Breast cancer is a heterogeneous disease with a large variabil- survival after adjuvant polychemotherapy was 10% (from ity in clinical outcome. (lu.se)
  • Some factors such as individual treatment strategy, according to the histology of the primary tumor, plan of treatment strategies carried out in a multidisciplinary manner, risk-benefit of radiotherapy, assessment of the degree of spinal instability, improvement in communication and referral between specialists in oncology showed an increase in the survival of these patients. (bvsalud.org)
  • Perioperative durvalumab plus neoadjuvant chemotherapy was associated with significantly greater event-free survival and pathological complete response than neoadjuvant chemotherapy alone, with a safety profile that was consistent with the individual agents. (cdc.gov)
  • Selected patients with histologic or cytologic proven stage IIIA-N2 NSCLC were given three cycles of platinum-based induction chemotherapy. (nih.gov)
  • Induction chemotherapy resulted in a response rate of 61% (95% confidence interval [CI] = 57% to 65%) among the 579 eligible patients. (nih.gov)
  • In view of its low morbidity and mortality, radiotherapy should be considered the preferred locoregional treatment for these patients. (nih.gov)
  • Patients had not received neoadjuvant radiotherapy or chemotherapy. (medscape.com)
  • Among the 1010 patients who received adjuvant platinum-based chemotherapy, the median DFS was 58.7 months in the pembrolizumab arm (n = 506) and 34.9 months in the placebo arm (hazard ratio, 0.73). (medscape.com)
  • In an exploratory subgroup analysis of the 167 patients who did not receive adjuvant chemotherapy, the DFS hazard ratio was 1.25. (medscape.com)
  • To assess long-term outcomes and toxicity of adjuvant radiotherapy in the post-surgical management of patients with resected high-grade skeletal osteosarcomas. (cun.es)
  • Seventy-two patients with primary resected osteosarcomas underwent adjuvant radiotherapy after neoadjuvant chemotherapy from December 1984 to December 2008. (cun.es)
  • To evaluate rates of vitreous relapse among retinoblastoma patients treated with primary chemotherapy and assess diode laser as a potential risk factor for relapse. (bmj.com)
  • Retrospective review of all patients treated with primary chemotherapy at a large ocular oncology centre. (bmj.com)
  • In February 1998 she joined the CRCTU as a Trial Coordinator coordinating a national, multicentre, phase III, trial called SECRAB which was designed to determine the optimal sequence of chemotherapy and radiotherapy in patients with early breast cancer. (birmingham.ac.uk)
  • 278 (97%) of 286 patients in the radiotherapy alone group and 254 (89%) of 287 in the combined-treatment group died during 5 years of follow-up. (nih.gov)
  • Radiotherapy and adjuvant chemotherapy may also be used in these patients. (gponline.com)
  • as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. (who.int)
  • Prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. (who.int)
  • Although radiotherapy has excellent local control rates, SPB has a high recurrence rate, with approximately 2/3 of patients in advanced stages progressing to additional solitary or multiple plasmacytomas [ 8 ]. (hindawi.com)
  • However, they have only analyzed relevant prognostic factors, and the data included were not comprehensive, such as the lack of data on radiotherapy or chemotherapy, which did not accurately predict the prognosis of patients with SPB. (hindawi.com)
  • Patients in both groups could receive up to four cycles of adjuvant chemotherapy, radiotherapy, or both. (ascopost.com)
  • Adjuvant chemotherapy was received by 11.9% of the patients in the nivolumab group and 22.2% of the control group. (ascopost.com)
  • Patients from the intervention groups of two separate randomized controlled trials were included: patients with breast cancer receiving neoadjuvant chemotherapy (n=74) and patients with locally advanced prostate cancer receiving treatment with radiotherapy (n=75). (jmir.org)
  • At a time when modern radiation treatment like intensity-modulated radiotherapy (IMRT) are accomplishing great good local control, distant metastases are getting to be the transcendent design of treatment failure, particularly in patients with locally progressed illness. (intechopen.com)
  • 16 patients (76%) received postoperative adjuvant radiotherapy. (smw.ch)
  • Adjuvant polychemotherapy (e.g. with 58% to 68%) for patients under the age of 50.1 Besides an cyclophosphamide, methotrexate and 5-fluorouracil (CMF)) or improvement in clinical outcome, these figures indicate that anthracycline-containing regimes, produce substantial reduc- a large proportion of the patients will never recur after the tion in recurrence and mortality. (lu.se)
  • Patients and methods proportion of the patients will recur despite treatment with adjuvant polychemotherapy. (lu.se)
  • Le protocole utilisé dans le traitement du myélome multiple a été le VMCD-REV à 76,92% avec pour réponse thérapeutique complète chez 6 patients, 3 réponses partielles et 4 en cours de traitement. (bvsalud.org)
  • Treatment of chondrosarcoma is predominantly surgical because adjuvant chemotherapy and radiotherapy are generally ineffective with the exception of dedifferentiated subtypes [ 11, 18 ]. (lww.com)
  • Both chemotherapy and radiotherapy reduce the risk of breast cancer recurring and the risk of dying from breast cancer. (cochrane.org)
  • To determine the effects of different sequencing of adjuvant CT and RT for women with early breast cancer. (cochrane.org)
  • Adjuvant treatment of operable breast cancer. (isciii.es)
  • For decades, 5-year tamoxifen administration was the gold standard for the adjuvant endocrine treatment of breast cancer ( 9 ). (spandidos-publications.com)
  • Adjuvant chemotherapy can be used before the main treatment to help make the tumour smaller, or after treatment, to kill residual cancer cells that may cause problems later in treatment. (melbendo.com.au)
  • Cite this: FDA OKs Pembrolizumab for Adjuvant Treatment of NSCLC - Medscape - Jan 27, 2023. (medscape.com)
  • The radiotherapy treatment usually consists of five consecutive sessions of 2 Gy rate per week for six weeks, the total treatment being 60 Gy 2 . (nature.com)
  • Consolidation chemotherapy is used to target cancer cells that are still in the body after initial treatment. (healthline.com)
  • Consolidation chemotherapy is used after initial treatment to target remaining cancer cells. (healthline.com)
  • Consolidation chemotherapy is administered after initial treatment to target cancers cells that may still be in your body. (healthline.com)
  • aTTom - adjuvant Tamoxifen Treatment Offer more? (birmingham.ac.uk)
  • Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas (AOA) is not yet well defined. (cochrane.org)
  • We included randomized controlled trials (RCTs) of adults with AO, AOA or anaplastic astrocytoma (AA) comparing adjuvant treatment of chemotherapy, RT, or sequential chemotherapy and RT. (cochrane.org)
  • Based on the differences in participant selection with respect to the definition of AO (two versus three high-risk anaplastic features), the inclusion of AA and sequence of treatment (RT and chemotherapy), we could not consider the results from the three RCTs for meta-analysis. (cochrane.org)
  • BT-ON013 trade name] treatment should only be initiated by a health care provider experienced in the administration of cytotoxic chemotherapy (see section 4.4), and should be administered by a health care provider only. (who.int)
  • Anthracyclines and taxanes are very important in the adjuvant treatment of BC. (isciii.es)
  • Grade 3 or 4 treatment-related adverse events occurred in 33.5% of the nivolumab-plus-chemotherapy group vs 36.9% of the chemotherapy-alone group. (ascopost.com)
  • NPC is mainly treated by RT and is profoundly radiosensitive and radiotherapy treatment is the spine of treatment for all stages of NPC without far off metastases. (intechopen.com)
  • There are numerous results from clinical trials looking at combined radiation treatment (RT) and chemotherapy for NPC. (intechopen.com)
  • Post-orchiectomy primary treatment for pure seminoma includes surveillance, radiotherapy, 0r chemotherapy. (medscape.com)
  • According to treatment guidelines in the regional care pro- recur in spite of chemotherapy. (lu.se)
  • In order to achieve a more effec- were recommended postoperative radiation and adjuvant tive and individualised chemotherapeutic treatment of breast chemotherapy. (lu.se)
  • Treatment that combines chemotherapy with radiotherapy. (bvsalud.org)
  • The most common side effects of chemotherapy are nausea and vomiting, fatigue (tiredness), alopecia (hair loss), muscular, nerve and blood effects, as well as bowel (constipation or diarrhoea) and oral problems. (melbendo.com.au)
  • The limited evidence available does suggest that the frequency and severity of side effects of chemotherapy and radiotherapy are similar regardless of which sequence is used. (cochrane.org)
  • As a result, the trials do not assess the modern types of radiotherapy, and new types of chemotherapy (such as taxanes) or other drugs (such as Herceptin). (cochrane.org)
  • Many advances in RT techniques and schedules are attempted to improve outcomes of the disease starting from intracavitary brachytherapy, intensity modulated RT to simultaneous modulated accelerated RT, all showing some promise with most significant benefit seen with addition of chemotherapy, especially in intermediate (Stage II) and advanced (Stage III, IVA, IVB) cases. (intechopen.com)
  • Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma. (dana-farber.org)
  • Individual tumour foci treated with laser hyperthermia were also coded for laser parameters including power settings, number of treatments, and concomitant administration of systemic chemotherapy (chemothermotherapy). (bmj.com)
  • Laser settings, number of hyperthermia treatments, and the concomitant use of systemic chemotherapy (chemothermotherapy) were not associated with higher rates of vitreous relapse. (bmj.com)
  • He went on to have a staging CT thorax, abdomen and pelvis, a nuclear bone scan and echocardiogram, before discussing systemic chemotherapy and chest wall radiotherapy. (gponline.com)
  • The addition of nivolumab to chemotherapy significantly improved pathologic complete response rate. (ascopost.com)
  • Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor? (bmj.com)
  • Nearly one in seven eyes with retinoblastoma treated with primary chemotherapy may develop vitreous relapse. (bmj.com)
  • The role of radiotherapy and chemoradiation in the management of primary liver tumours. (cancercentrum.se)
  • The benefit of adjuvant chemotherapy and radiotherapy (RT), given as single modalities or sequentially, is still unclear. (cochrane.org)
  • The trial supported the March 2022 approval of nivolumab combined with platinum-doublet chemotherapy for resectable NSCLC in the neoadjuvant setting. (ascopost.com)
  • We excluded no specific chemotherapy regimens. (cochrane.org)
  • Although TNBC has a variety of different subtypes that may vary depending on how they are determined, to date the disease is still uniformly treated with chemotherapy although they may have additional targeted treatments. (wikipedia.org)
  • Eyes that developed vitreous relapse were coded with regard to Reese-Ellsworth Group, laterality, time to relapse, type of relapse (vitreous base or non-vitreous base relapse), treatments used (including adjuvant diode laser), and ocular preservation. (bmj.com)
  • Adjuvant chemotherapy is used after other treatments to shrink remaining cancer cells. (healthline.com)
  • Trastuzumab in combination with adjuvant chemotherapy has changed the natural history of early Her-2 positive BC. (isciii.es)
  • Chemotherapy concerns the use of special cytotoxic drugs to treat cancers by either killing the cancer cells or slowing their growth. (melbendo.com.au)
  • There are many different combinations of chemotherapy used to treat various cancers, and these may have different effects on different people. (melbendo.com.au)
  • Stereotactic body radiotherapy (SBRT) is a single high-dose radiotherapy used to treat a variety of cancers. (frontiersin.org)
  • The patient received adjuvant third-generation chemotherapy with a taxane and an anthracycline, followed by radiotherapy to the breast, supraclavicular fossa and axilla. (cmaj.ca)
  • RESULTS: Neoadjuvant chemotherapy consisted of a combination of platinum based agents (n = 19) with gemcitabine (n = 15) or pemetrexed (n = 4). (smw.ch)
  • In some instances, chemotherapy may not be able to control the cancer, but indicated to relieve symptoms such as pain and help you lead as normal a life as is possible. (melbendo.com.au)
  • We examined expression levels of organic anion-transporting polypeptide (OATP)1B1, OATP1B3, OATP1B7, and organic anion transporter (OAT)1 as solute carrier transporters and multidrug resistance-associated protein (MRP)1 and MRP2 as ATP-binding cassette transporters, using real-time polymerase chain reaction and accumulation of 3 H-MTX in cancer cells after 10-Gy irradiation, assuming stereotactic body radiotherapy. (frontiersin.org)
  • Chemicals in chemotherapy drugs target cells that rapidly divide, such as cancer cells. (healthline.com)
  • Uneétude descriptive, transversale portant sur les patientes traitées en radiothérapie à l'Hôpital Général de Douala pour cancer du col de l'utérus a été réalisée d'octobre 2020 à janvier 2021.Résultats. (bvsalud.org)